Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Histologic Progression”

545 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 545 results

Not applicableStudy completedNCT01764529
What this trial is testing

Modifiers of Disease Severity in Cerebral Cavernous Malformations

Who this might be right for
Cavernous Angioma, FamilialCerebral Cavernous MalformationsCerebral Cavernous Hemangioma
University of California, San Francisco 789
Post-approval studies (Phase 4)UnknownNCT03150602
What this trial is testing

A Pralatrexate Study in Asian Patients With Peripheral T-cell Lymphoma After Prior Therapy

Who this might be right for
Peripheral T Cell LymphomaProgression, Disease
Taiwan Mundipharma Pharmaceuticals Ltd. 22
Large-scale testing (Phase 3)Study completedNCT03366272
What this trial is testing

Nivolumab With Gemcitabine, Oxaliplatin + Rituximab in r/r Elderly Lymphoma Patients

Who this might be right for
Lymphoma, Non-Hodgkin
Universität des Saarlandes 348
Testing effectiveness (Phase 2)Looking for participantsNCT07322263
What this trial is testing

Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC

Who this might be right for
Bladder CancerNon-Muscle Invasive Bladder Cancer (NMIBC)Urothelial Carcinoma+8 more
Michael A. O'Donnell 174
Testing effectiveness (Phase 2)Active Not RecruitingNCT04207944
What this trial is testing

The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial)

Who this might be right for
IPMNIPMN, Pancreatic
Duke University 100
Testing effectiveness (Phase 2)Looking for participantsNCT03556228
What this trial is testing

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

Who this might be right for
Head and Neck CarcinomaAdenoid Cystic CarcinomaLung Cancer+22 more
VM Oncology, LLC 242
Not applicableEnded earlyNCT04488263
What this trial is testing

Natural History Study of Children and Adults With Neuroendocrine Neoplasms (NEN)s

Who this might be right for
Neuroendocrine TumorsCarcinoma, Neuroendocrine
National Cancer Institute (NCI) 30
Not applicableNot Yet RecruitingNCT07542912
What this trial is testing

Sintilimab, Chidamide, and Azacitidine for Untreated Stage I-II Extranodal NK/T-Cell Lymphoma

Who this might be right for
Complete Remission Rate， CRRProgression Free SurvivalOverall Survival+2 more
Sun Yat-sen University 30
Not applicableActive Not RecruitingNCT04358107
What this trial is testing

Optimal Methods of Disease Progression and Survival Analysis in Children and Adults Patients With Adrenocortical Cancer (ACC)

Who this might be right for
Adrenocortical Carcinoma
National Cancer Institute (NCI) 1,000
Testing effectiveness (Phase 2)UnknownNCT06170697
What this trial is testing

Advanced First-line Treatment of Short-term Postoperative Progression of Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 46
Testing effectiveness (Phase 2)Study completedNCT02471313
What this trial is testing

Integrated Imaging Strategy to Phenotype Progression of Liver Tumors During and After Chemoembolization

Who this might be right for
Liver CancerLiver NeoplasmHepatocellular Carcinoma+1 more
National Institutes of Health Clinical Center (CC) 3
Not applicableUnknownNCT05426317
What this trial is testing

Exploratory Interventional Study of Prognostic Serum Biomarkers of Cancer Progression

Who this might be right for
MelanomaNon Small Cell Lung CancerRenal Cancer
University Hospital, Clermont-Ferrand 100
Early research (Phase 1)Study completedNCT00272350
What this trial is testing

ZD6474 to Treat Advanced Brain Cancer in Patients

Who this might be right for
Recurrent High-Grade GliomasProgressive Low-Grade GliomasMalignant Gliomas
National Cancer Institute (NCI) 83
Post-approval studies (Phase 4)Ended earlyNCT00352859
What this trial is testing

Phase IV Randomization to On-Going Treatment to Evaluate Sustained Sorafenib

Who this might be right for
Carcinoma, Renal Cell
Bayer 2
Testing effectiveness (Phase 2)UnknownNCT04039516
What this trial is testing

Carcinoid Heart Disease and Peptide Receptor Radiotargetted Therapy

Who this might be right for
Carcinoid Heart DiseaseCarcinoid SyndromeCarcinoid Tumor
King's College Hospital NHS Trust 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT03076554
What this trial is testing

A Pilot Study to Investigate the Safety and Clinical Activity of Avelumab (MSB0010718C) in Thymoma and Thymic Carcinoma After Progression on Platinum-Based Chemotherapy

Who this might be right for
ThymomaThymic Carcinoma
National Cancer Institute (NCI) 56
Not applicableLooking for participantsNCT07121842
What this trial is testing

Glioblastoma Imaging for the Detection of Tumor Progression Using APTw-CEST MRI

Who this might be right for
Glioblastoma
Erasmus Medical Center 120
Not applicableActive Not RecruitingNCT03728842
What this trial is testing

Spontaneous Regression in Metastatic Melanoma and Renal Cell Carcinoma

Who this might be right for
Melanoma; Renal Cell Carcinoma
Indiana University 19
Not applicableActive Not RecruitingNCT06751251
What this trial is testing

The Exploration of OX40 (CD134) Expression Levels in Sarcoma Specimens and Its Clinical Application in Prognosis Determination

Who this might be right for
SarcomaBiomarkersProgression
Peking University People's Hospital 200
Testing effectiveness (Phase 2)Looking for participantsNCT05779423
What this trial is testing

Cryoablation+Ipilimumab+Nivolumab in Melanoma

Who this might be right for
Metastatic MelanomaSkin Cancer
Massachusetts General Hospital 37
Next Page